2161 — Jbm (Healthcare) Cashflow Statement
0.000.00%
Last trade - 00:00- HK$1.25bn
- HK$1.58bn
- HK$834.63m
Annual cashflow statement for Jbm (Healthcare), fiscal year end - March 31st, HKD millions except per share, conversion factor applied.
2022 March 31st | 2023 March 31st | 2024 March 31st | 2025 March 31st | 2026 March 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | 30.7 | 76.9 | 165 | 242 | 252 |
| Depreciation | |||||
| Non-Cash Items | 10.7 | 1.35 | 13.1 | 7.55 | 29.9 |
| Unusual Items | |||||
| Equity in Net Earnings/Losses | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -29.2 | 23.7 | -33.3 | -74.6 | -169 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Payable / Accrued Expenses | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | 60 | 146 | 191 | 227 | 162 |
| Capital Expenditures | -7.06 | -8.13 | -10.2 | -21 | -33.3 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | -0.493 | 1.35 | 18.5 | -99.5 | -126 |
| Acquisition of Business | |||||
| Sale of Business | |||||
| Sale of Fixed Assets | |||||
| Sale/Maturity of Investment | |||||
| Purchase of Investments | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -7.55 | -6.78 | 8.31 | -120 | -159 |
| Financing Cash Flow Items | -7.37 | -8.97 | -9.46 | 40.4 | -109 |
| Other Financing Cash Flow | |||||
| Total Cash Dividends Paid | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | -76.9 | -56 | -211 | -41.5 | -89.3 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | -24.5 | 82.4 | -11.5 | 65 | -85.9 |